Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-23

FDA Approved: VALACYCLOVIR — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)

View source ↗

Summary

FDA approved a supplemental application for valacyclovir from Sun Pharmaceutical Industries, a generic antiviral indicated for herpes infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valacyclovir (Valacyclovir)

Snippet

SUPPL AP for VALACYCLOVIR (VALACYCLOVIR)